Child Neurology: Progressive Cerebellar Atrophy and Retinal Dystrophy: Clues to an Ultrarare ACO2-Related Neurometabolic Diagnosis

Neurology. 2023 Oct 10;101(15):e1567-e1571. doi: 10.1212/WNL.0000000000207649. Epub 2023 Jul 17.

Abstract

Pathogenic biallelic variants in ACO2, which encodes the enzyme mitochondrial aconitase, are associated with the very rare diagnosis of ACO2-related infantile cerebellar retinal degeneration (OMIM 614559). We describe the diagnostic odyssey of a 4-year-old female patient with profound global developmental delays, microcephaly, severe hypotonia, retinal dystrophy, seizures, and progressive cerebellar atrophy. Whole-exome sequencing revealed 2 variants in ACO2; c.2105_2106delAG (p.Gln702ArgfsX9), a likely pathogenic variant, and c.988C>T (p.Pro330Ser) which was classified as a variant of uncertain significance (VUS). While the VUS was confirmed to be maternally inherited, the phase of the other variant could not be confirmed due to lack of a paternal sample. Functional biochemical studies were performed on a research basis to clarify the interpretation of the VUS, which enabled clinical confirmation of the diagnosis of ACO2-related infantile cerebellar retinal degeneration for our patient.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Aconitate Hydratase
  • Atrophy
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Microcephaly*
  • Nervous System Malformations*
  • Retinal Dystrophies* / diagnosis
  • Retinal Dystrophies* / genetics

Substances

  • Aconitate Hydratase
  • ACO2 protein, human